2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Head & Neck
5
Thoracic
2
Other solid neoplasm
2
NET
2
Gynecologic
2
Gastrointestinal
2
Endocrine
2
Dermatologic
2
Sarcoma
1
Plasma cell
1
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Genitourinary
1
CNS
1
Breast
1
Conditions
Brain Neoplasms
2313
Glioblastoma
2016
Glioma
1402
Central Nervous System Neoplasms
692
Astrocytoma
668
Neuroblastoma
647
Gliosarcoma
480
Oligodendroglioma
405
Neoplasms
405
Breast Neoplasms
327
Medulloblastoma
307
Carcinoma, Non-Small-Cell Lung
256
Meningioma
229
Recurrence
224
Sarcoma
215
Melanoma
207
Neoplasm Metastasis
202
Ependymoma
200
Lung Neoplasms
199
Neurofibromatosis 1
169
Lymphoma
162
Meningeal Carcinomatosis
138
Osteosarcoma
135
Ovarian Neoplasms
132
Wilms Tumor
123
Precursor Cell Lymphoblastic Leukemia-Lymphoma
123
Head and Neck Neoplasms
117
Lymphoma, Non-Hodgkin
116
Diffuse Intrinsic Pontine Glioma
113
Rhabdomyosarcoma
107
Interventions
Quality of Life
1
Patient Reported Outcome Measures
1
Molecular Diagnostic Techniques
1
Immunotherapy
1
Drug Therapy
1
Biological Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Parotid Neoplasms
×
CNS
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled